What does BioNexus Gene Lab Corp do?

BioNexus Gene Lab Corp is a public company in the Services-Medical Laboratories industry, incorporated in WY. It is registered with the SEC under CIK 0001737523 and trades on NASDAQ under the ticker BGLC.

What is BioNexus Gene Lab Corp's annual revenue?

BioNexus Gene Lab Corp reported $7.42M in revenue for fiscal year 2025, according to its 10-K filing with the SEC.

Is BioNexus Gene Lab Corp profitable?

BioNexus Gene Lab Corp reported a net loss of $2.98M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has BioNexus Gene Lab Corp made?

BioNexus Gene Lab Corp has filed 137 documents with the SEC since 2019. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

BioNexus Gene Lab Corp

BGLC NASDAQ CIK: 0001737523 Services-Medical Laboratories Inc. in WY

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 137 filings →

Form	Description	Date
8-K	FORM 8-K	Mar 17, 2026
8-K	FORM 8-K	Feb 23, 2026
8-K	FORM 8-K	Feb 3, 2026
8-K	FORM 8-K	Dec 30, 2025
8-K	FORM 8-K	Dec 23, 2025
DEF 14A	DEF 14A	Dec 3, 2025
8-K	FORM 8-K	Dec 2, 2025
10-Q	FORM 10-Q	Nov 14, 2025
PRE 14A	PRE 14A	Nov 14, 2025
8-K	FORM 8-K	Nov 13, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for BioNexus Gene Lab Corp. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $7.42M (FY2025)
Net Income: ($2.98M) (FY2025)
Total Assets: $9.25M (FY2025)
Operating Income: ($2.97M)

Full financials →

Details

CIK: 0001737523
Ticker: BGLC
Exchange: NASDAQ
Incorporated: WY
First Filing: 2019
Total Filings: 137

Services-Medical Laboratories rankings →